ArticleFrontiers in pharmacology2022

Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers.

Jaime Algorta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.